These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18292394)

  • 1. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
    Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
    Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
    Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M; Korandji C; Guilland JC; Sicard P; Vergely C; Lorgis L; Beer JC; Duvillard L; Lagrost AC; Moreau D; Gambert P; Cottin Y; Rochette L
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
    Lu TM; Chung MY; Lin CC; Hsu CP; Lin SJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1566-72. PubMed ID: 21642363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.
    Cavusoglu E; Ruwende C; Chopra V; Poludasu S; Yanamadala S; Frishman WH; Eng C; Pinsky DJ; Marmur JD
    Atherosclerosis; 2010 May; 210(1):226-31. PubMed ID: 19944421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
    Böger RH; Sullivan LM; Schwedhelm E; Wang TJ; Maas R; Benjamin EJ; Schulze F; Xanthakis V; Benndorf RA; Vasan RS
    Circulation; 2009 Mar; 119(12):1592-600. PubMed ID: 19289633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
    Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
    Schnabel R; Blankenberg S; Lubos E; Lackner KJ; Rupprecht HJ; Espinola-Klein C; Jachmann N; Post F; Peetz D; Bickel C; Cambien F; Tiret L; Münzel T
    Circ Res; 2005 Sep; 97(5):e53-9. PubMed ID: 16100045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
    Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
    Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study.
    Rohrmann S; Garmo H; Malmström H; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
    Atherosclerosis; 2016 Aug; 251():85-93. PubMed ID: 27289190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
    Mamatha SN; Nagaraja D; Philip M; Christopher R
    Clin Chim Acta; 2011 Jan; 412(1-2):139-42. PubMed ID: 20883678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
    Gore MO; Lüneburg N; Schwedhelm E; Ayers CR; Anderssohn M; Khera A; Atzler D; de Lemos JA; Grant PJ; McGuire DK; Böger RH
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2682-8. PubMed ID: 24008162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
    Yu E; Ruiz-Canela M; Hu FB; Clish CB; Corella D; Salas-Salvadó J; Hruby A; Fitó M; Liang L; Toledo E; Ros E; Estruch R; Gómez-Gracia E; Lapetra J; Arós F; Romaguera D; Serra-Majem L; Guasch-Ferré M; Wang DD; Martínez-González MA
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1879-1888. PubMed ID: 28323949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.